Please try another search
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company’s products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.
Name | Age | Since | Title |
---|---|---|---|
Roger James Pomerantz | 64 | 2020 | Independent Chairman of the Board |
Yehiel Tal | 70 | 2010 | CEO & Director |
Joseph M. Lane | - | - | Member of the Scientific Advisory Board & Member of the Clinical Advisory Board |
Avram Hershko | 85 | - | Member of the Scientific Advisory Board |
Ofer Levy | - | - | Member of the Scientific Advisory Board & Member of the Clinical Advisory Board |
Abhay Pandit | - | - | Member of the Scientific Advisory Board |
Vicki Rosen | - | - | Member of the Scientific Advisory Board |
Abraham Havron | 74 | 2016 | Independent Director |
Elan Penn | 71 | 2018 | Independent Director |
Shay Soker | - | 2018 | Member of Advisory Board |
Joseph Zarzewsky | 62 | 2019 | Independent Director |
Hugh M. Evans | 57 | 2021 | Independent Director |
Alisa Lask | 52 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review